ClinicalTrials.gov
public full text
Public Domain
Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR
The primary objective of this study was to compare the relative efficacy of Budesonide administered via Captisol-Enabled Budesonide nasal solution and Rhinocort Aqua in patients with seasonal allergic rhinitis (SAR) exposed to controlled ragweed pollen using an EEC model.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber#864004
- Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine#1009492
- Comparison of Skin Prick Testing Results of Local and Imported Pollen Allergen Extracts and Specific IgE#918101
- Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy#813552
- Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy#154742
Record · ID 904396
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive